ROBERT F FRIEL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROBERT F FRIEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROBERT F FRIEL. ROBERT F FRIEL is Chairman and CEO in PERKINELMER INC ($PKI) and Chief Financial Officer in PERKINELMER INC ($PKI) and Executive VP & CFO in PERKINELMER INC ($PKI) and President and CEO in PERKINELMER INC ($PKI) and Vice Chairman in PERKINELMER INC ($PKI) and in WEST PHARMACEUTICAL SERVICES INC ($WST) and Director in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in NUVASIVE INC ($NUVA) and Director in CAREFUSION Corp ($CFN) and Director in Xylem Inc. ($XYL).
Latest Insider Trading Transactions of ROBERT F FRIEL
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CFN, MLNM, NUVA, PKI, WST, XYL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 1,925 | 0 | 26,735 | 24.8 K to 26.7 K (+7.76 %) |
| May 06 2021 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 577 | 0 | 1,799 | 1.2 K to 1.8 K (+47.22 %) | |
| May 29 2020 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 3,095 | 0 | 3,095 | |
| May 14 2020 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 3,737 | 0 | 24,596 | 20.9 K to 24.6 K (+17.92 %) |
| May 07 2020 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 975 | 0 | 1,219 | 244 to 1.2 K (+399.59 %) | |
| Feb 20 2020 | WST | WEST PHARMACEUTICA ... | FRIEL ROBERT F | Grant | A | 0.00 | 244 | 0 | 244 | 0 to 244 | |
| May 17 2019 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 1,831 | 0 | 20,718 | 18.9 K to 20.7 K (+9.69 %) |
| May 10 2019 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 2,577 | 0 | 2,577 | |
| Feb 14 2019 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chairman and CEO | Payment of Exercise | F | 91.83 | 16,889 | 1,550,917 | 570,662 | 587.6 K to 570.7 K (-2.87 %) |
| Feb 07 2019 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chairman and CEO | Option Exercise | A | 92.09 | 62,059 | 5,715,013 | 62,059 | |
| Feb 07 2019 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chairman and CEO | Grant | A | 0.00 | 14,894 | 0 | 587,551 | 572.7 K to 587.6 K (+2.60 %) |
| Oct 02 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 33.87 | 150,612 | 5,101,228 | 0 | |
| Oct 02 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 97.73 | 46,315 | 4,526,365 | 572,657 | 619 K to 572.7 K (-7.48 %) |
| Oct 02 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 96.75 | 104,297 | 10,090,735 | 618,972 | 723.3 K to 619 K (-14.42 %) |
| Oct 02 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 33.87 | 150,612 | 5,101,228 | 723,269 | 572.7 K to 723.3 K (+26.30 %) |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 26.15 | 215,870 | 5,643,921 | 0 | |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 26.15 | 2,709 | 70,827 | 215,870 | |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 81.62 | 215,870 | 17,619,309 | 572,657 | 788.5 K to 572.7 K (-27.38 %) |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 26.15 | 215,870 | 5,643,921 | 788,527 | 572.7 K to 788.5 K (+37.70 %) |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 80.00 | 2,709 | 216,723 | 572,657 | 575.4 K to 572.7 K (-0.47 %) |
| Aug 03 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 26.15 | 2,709 | 70,827 | 575,366 | 572.7 K to 575.4 K (+0.47 %) |
| May 10 2018 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 1,947 | 0 | 18,805 | 16.9 K to 18.8 K (+11.55 %) |
| May 07 2018 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 3,230 | 0 | 3,230 | |
| Feb 07 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Payment of Exercise | F | 78.08 | 16,374 | 1,278,482 | 572,657 | 589 K to 572.7 K (-2.78 %) |
| Feb 01 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | A | 81.05 | 75,947 | 6,155,504 | 75,947 | |
| Feb 01 2018 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Grant | A | 0.00 | 17,060 | 0 | 589,031 | 572 K to 589 K (+2.98 %) |
| May 22 2017 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 2,130 | 0 | 2,130 | |
| May 11 2017 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 2,743 | 0 | 16,811 | 14.1 K to 16.8 K (+19.50 %) |
| May 03 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 26.58 | 48,400 | 1,286,472 | 25,100 | |
| May 03 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 60.01 | 48,400 | 2,904,484 | 571,971 | 620.4 K to 572 K (-7.80 %) |
| May 03 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 26.58 | 48,400 | 1,286,472 | 620,371 | 572 K to 620.4 K (+8.46 %) |
| Apr 28 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 26.58 | 124,837 | 3,318,167 | 73,500 | |
| Apr 28 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 60.11 | 124,837 | 7,503,952 | 571,973 | 696.8 K to 572 K (-17.92 %) |
| Apr 28 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 26.58 | 124,837 | 3,318,167 | 696,810 | 572 K to 696.8 K (+21.83 %) |
| Feb 08 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | A | 52.69 | 115,221 | 6,070,994 | 115,221 | |
| Feb 08 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Grant | A | 0.00 | 25,223 | 0 | 571,973 | 546.8 K to 572 K (+4.61 %) |
| Feb 08 2017 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Payment of Exercise | F | 52.17 | 15,781 | 823,295 | 546,750 | 562.5 K to 546.8 K (-2.81 %) |
| May 26 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 21.01 | 128,300 | 2,694,942 | 0 | |
| May 26 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 55.01 | 128,300 | 7,057,783 | 562,531 | 690.8 K to 562.5 K (-18.57 %) |
| May 26 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 21.01 | 128,300 | 2,694,942 | 690,831 | 562.5 K to 690.8 K (+22.81 %) |
| May 23 2016 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 2,822 | 0 | 2,822 | |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 21.01 | 101,578 | 2,133,646 | 128,300 | |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 21.01 | 7,422 | 155,899 | 229,878 | |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 55.01 | 101,578 | 5,587,806 | 562,531 | 664.1 K to 562.5 K (-15.30 %) |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 21.01 | 101,578 | 2,133,646 | 664,109 | 562.5 K to 664.1 K (+18.06 %) |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 55.01 | 7,422 | 408,284 | 562,531 | 570 K to 562.5 K (-1.30 %) |
| May 17 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 21.01 | 7,422 | 155,899 | 569,953 | 562.5 K to 570 K (+1.32 %) |
| May 12 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 21.01 | 10,685 | 224,438 | 237,300 | |
| May 12 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 55.01 | 10,685 | 587,782 | 562,531 | 573.2 K to 562.5 K (-1.86 %) |
| May 12 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 21.01 | 10,685 | 224,438 | 573,216 | 562.5 K to 573.2 K (+1.90 %) |
| May 12 2016 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 2,799 | 0 | 14,051 | 11.3 K to 14.1 K (+24.88 %) |
| May 09 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | M | 21.01 | 4,116 | 86,457 | 247,985 | |
| May 09 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Sell | S | 55.00 | 4,116 | 226,380 | 562,531 | 566.6 K to 562.5 K (-0.73 %) |
| May 09 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Buy | M | 21.01 | 4,116 | 86,457 | 566,647 | 562.5 K to 566.6 K (+0.73 %) |
| Feb 10 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Option Exercise | A | 42.47 | 187,655 | 7,969,708 | 187,655 | |
| Feb 10 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Grant | A | 0.00 | 41,716 | 0 | 562,531 | 520.8 K to 562.5 K (+8.01 %) |
| Feb 08 2016 | PKI | PERKINELMER INC | FRIEL ROBERT F | President and CEO | Payment of Exercise | F | 46.58 | 19,544 | 910,360 | 520,815 | 540.4 K to 520.8 K (-3.62 %) |
| Feb 17 2016 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 850 | 0 | 850 | |
| Feb 17 2016 | NUVA | NUVASIVE INC | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 5,113 | 0 | 5,113 | |
| May 13 2015 | XYL | Xylem Inc. | FRIEL ROBERT F | Director | Grant | A | 0.00 | 3,289 | 0 | 11,229 | 7.9 K to 11.2 K (+41.42 %) |
| Mar 19 2015 | CFN | CAREFUSION Corp | FRIEL ROBERT F | Director | Option Exercise | D | 0.00 | 2,874 | 0 | 0 | |
| Mar 19 2015 | CFN | CAREFUSION Corp | FRIEL ROBERT F | Director | Buy | D | 0.00 | 34,103 | 0 | 0 | -34,103 to 0 (-100.00 %) |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 10.87 | 18,333 | 199,280 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 10.99 | 6,667 | 73,270 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 9.97 | 6,041 | 60,229 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 8.36 | 2,517 | 21,042 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 8.99 | 3,699 | 33,254 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 10.08 | 11,666 | 117,593 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 9.94 | 11,667 | 115,970 | 0 | |
| May 15 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | D | 8.00 | 7,535 | 60,280 | 0 | |
| May 12 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Sell | U | 25.00 | 12,408 | 310,200 | 0 | 12.4 K to 0 (-100.00 %) |
| Jan 17 2008 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Grant | A | 0.00 | 481 | 0 | 12,408 | 11.9 K to 12.4 K (+4.03 %) |
| Oct 17 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Grant | A | 0.00 | 686 | 0 | 11,927 | 11.2 K to 11.9 K (+6.10 %) |
| Jul 31 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Grant | A | 0.00 | 660 | 0 | 11,241 | 10.6 K to 11.2 K (+6.24 %) |
| Jun 04 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 10.87 | 18,333 | 199,280 | 18,333 | |
| Jun 04 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| May 14 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Grant | A | 0.00 | 581 | 0 | 10,581 | 10 K to 10.6 K (+5.81 %) |
| May 02 2007 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 10.99 | 6,667 | 73,270 | 6,667 | |
| Jan 26 2007 | PKI | PERKINELMER INC | FRIEL ROBERT F | Vice Chairman | Sell | D | 0.00 | 10,000 | 0 | 274,717 | 284.7 K to 274.7 K (-3.51 %) |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | M | 8.36 | 3,525 | 29,469 | 2,517 | |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | M | 8.99 | 2,343 | 21,064 | 3,699 | |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | M | 8.00 | 4,132 | 33,056 | 7,535 | |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Buy | M | 8.36 | 3,525 | 29,469 | 10,000 | 6.5 K to 10 K (+54.44 %) |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Buy | M | 8.99 | 2,343 | 21,064 | 6,475 | 4.1 K to 6.5 K (+56.70 %) |
| Dec 12 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Buy | M | 8.00 | 4,132 | 33,056 | 4,132 | 0 to 4.1 K |
| Jul 05 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 9.97 | 6,041 | 60,229 | 6,041 | |
| Jun 02 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 8.36 | 6,042 | 50,511 | 6,042 | |
| May 03 2006 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 8.99 | 6,042 | 54,318 | 6,042 | |
| Feb 02 2006 | PKI | PERKINELMER INC | FRIEL ROBERT F | Vice Chairman | Option Exercise | A | 22.58 | 101,130 | 2,283,515 | 101,130 | |
| Feb 02 2006 | PKI | PERKINELMER INC | FRIEL ROBERT F | Vice Chairman | Grant | A | 0.00 | 50,565 | 0 | 284,717 | 234.2 K to 284.7 K (+21.59 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Option Exercise | M | 14.22 | 150,000 | 2,133,000 | 0 | |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.22 | 7,400 | 157,028 | 234,152 | 241.6 K to 234.2 K (-3.06 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.23 | 2,500 | 53,075 | 251,552 | 254.1 K to 251.6 K (-0.98 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.29 | 2,000 | 42,580 | 244,052 | 246.1 K to 244.1 K (-0.81 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.24 | 2,500 | 53,100 | 246,052 | 248.6 K to 246.1 K (-1.01 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.25 | 2,500 | 53,125 | 248,552 | 251.1 K to 248.6 K (-1.00 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.28 | 5,000 | 106,400 | 251,052 | 256.1 K to 251.1 K (-1.95 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.26 | 5,000 | 106,300 | 256,052 | 261.1 K to 256.1 K (-1.92 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.29 | 5,000 | 106,450 | 261,052 | 266.1 K to 261.1 K (-1.88 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.21 | 27,100 | 574,791 | 266,052 | 293.2 K to 266.1 K (-9.24 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.29 | 30,000 | 638,700 | 293,152 | 323.2 K to 293.2 K (-9.28 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.28 | 25,000 | 532,000 | 323,152 | 348.2 K to 323.2 K (-7.18 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.48 | 21,300 | 457,524 | 348,152 | 369.5 K to 348.2 K (-5.77 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Sell | S | 21.35 | 14,700 | 313,845 | 369,142 | 383.8 K to 369.1 K (-3.83 %) |
| Nov 01 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Executive VP & CFO | Buy | M | 14.22 | 150,000 | 2,133,000 | 384,152 | 234.2 K to 384.2 K (+64.06 %) |
| Aug 17 2005 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 10.08 | 11,666 | 117,593 | 11,666 | |
| Jul 19 2005 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 9.94 | 11,667 | 115,970 | 11,667 | |
| Jun 17 2005 | MLNM | MILLENNIUM PHARMAC ... | FRIEL ROBERT F | Director | Option Exercise | A | 8.00 | 11,667 | 93,336 | 11,667 | |
| Jan 27 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Grant | A | 21.02 | 46,304 | 973,310 | 231,273 | 185 K to 231.3 K (+25.03 %) |
| Jan 05 2005 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Option Exercise | A | 22.22 | 85,000 | 1,888,700 | 85,000 | |
| Jan 29 2004 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Buy | J | 0.00 | 68 | 0 | 2,859 | 2.8 K to 2.9 K (+2.44 %) |
| Jan 29 2004 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Buy | J | 0.00 | 1,483 | 0 | 184,494 | 183 K to 184.5 K (+0.81 %) |
| Jan 29 2004 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 183,011 | 153 K to 183 K (+19.61 %) |
| Oct 24 2003 | PKI | PERKINELMER INC | FRIEL ROBERT F | Chief Financial Off ... | Option Exercise | A | 16.44 | 141,000 | 2,318,040 | 141,000 |
Page: 1